Inhibition of sEH is of great clinical interest as it has also been shown to reduce neuroinflammation and cognitive impairment in animal models of cerebral hypoperfusion and type 1 and type 2 diabetes mellitus [29,30,31,32,33]. The gene discussed is EPHX2; the disease is diabetes mellitus.